CCMI
ADMA icon

Creative Capital Management Investments’s ADMA Biologics ADMA Stock Holding History

Creative Capital Management Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176 Buy
+21
New +$191 ﹤0.01% 1398

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Creative Capital Management Investments's ADMA Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in ADMA Biologics (ADMA) in Q2 2026: 21 shares worth $176. The stake represents ﹤0.01% of the portfolio and ranks #1398 among its holdings.

62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Creative Capital Management Investments held 21 shares of ADMA Biologics worth $176 as of Q2 2026.
  • ADMA Biologics was a new Creative Capital Management Investments position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1398 holding.
  • 62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.